149 related articles for article (PubMed ID: 8071570)
1. Intracellular action of an exogenous low-molecular-weight synthetic protease inhibitor, E3123, in cerulein-induced acute pancreatitis in rats.
Sata N; Atomi Y; Kimura W; Kuroda A; Muto T; Mineo C
Int J Pancreatol; 1994 Apr; 15(2):119-27. PubMed ID: 8071570
[TBL] [Abstract][Full Text] [Related]
2. Distribution of a synthetic protease inhibitor in rat pancreatic acini after supramaximal secretagogue stimulation.
Otani T; Atomi Y; Kuroda A; Muto T; Tamura M; Fukuda S; Akao S; Gorelick FS
Pancreas; 1997 Mar; 14(2):142-9. PubMed ID: 9057186
[TBL] [Abstract][Full Text] [Related]
3. Cytoprotective effects of prostaglandins and a new potent protease inhibitor in acute pancreatitis.
Hirano T; Manabe T; Tobe T
Am J Med Sci; 1992 Sep; 304(3):154-63. PubMed ID: 1282294
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of prophylaxis with a protease inhibitor and a free radical scavenger against a temporary ischemia model of pancreatitis.
Hirano T; Furuyama H; Kawakami Y; Ando K; Tsuchitani T
Can J Surg; 1995 Jun; 38(3):241-8. PubMed ID: 7540502
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of a cephalosporin, Shiomarin, plus a new potent protease inhibitor, E3123, on rat taurocholate-induced pancreatitis.
Hirano T; Manabe T; Imanishi K; Tobe T
J Gastroenterol Hepatol; 1993; 8(1):52-9. PubMed ID: 8439663
[TBL] [Abstract][Full Text] [Related]
6. Peptide leukotriene receptor antagonist diminishes pancreatic edema formation in rats with cerulein-induced acute pancreatitis.
Hirano T
Scand J Gastroenterol; 1997 Jan; 32(1):84-8. PubMed ID: 9018772
[TBL] [Abstract][Full Text] [Related]
7. Combined therapy of a cephalosporin, Shiomarin and a new potent protease inhibitor, E3123 in rat taurocholate-induced pancreatitis.
Hirano T; Manabe T
Nihon Geka Hokan; 1992 Nov; 61(6):423-32. PubMed ID: 1306980
[TBL] [Abstract][Full Text] [Related]
8. Effect of short-termed pancreatico-biliary duct obstruction on lysosomal enzyme in rats: protective effect of a potent new protease inhibitor, E-3123.
Hirano T; Manabe T; Yotsumoto F; Ohshio G; Nio Y
Nihon Geka Hokan; 1992 May; 61(3):234-48. PubMed ID: 1280076
[TBL] [Abstract][Full Text] [Related]
9. Protection by a new synthetic protease inhibitor, ONO3307, of the rat exocrine pancreas during acute edematous pancreatitis induced by a supramaximal dose of caerulein in comparison with FOY007.
Hirano T; Manabe T; Tobe T
Pharmacology; 1992; 45(2):107-16. PubMed ID: 1381836
[TBL] [Abstract][Full Text] [Related]
10. Effect of the microtubule-disrupting drug colchicine on rat cerulein-induced pancreatitis in comparison with the microtubule stabilizer taxol.
Ueda T; Takeyama Y; Adachi M; Toyokawa A; Kishida S; Yamamoto M; Saitoh Y
Pancreas; 1995 Oct; 11(3):294-302. PubMed ID: 8577685
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of nafamostat mesilate on cellular and lysosomal fragility of acinar cells in rat cerulein pancreatitis.
Manabe T; Hirano T; Imanishi K; Ando K; Yotsumoto F; Tobe T
Int J Pancreatol; 1992 Oct; 12(2):167-72. PubMed ID: 1281204
[TBL] [Abstract][Full Text] [Related]
12. Human urinary trypsin inhibitor, urinastatin, prevents pancreatic injuries induced by pancreaticobiliary duct obstruction with cerulein stimulation and systemic hypotension in the rat.
Hirano T; Manabe T
Arch Surg; 1993 Dec; 128(12):1322-9; discussion 1329. PubMed ID: 7504442
[TBL] [Abstract][Full Text] [Related]
13. The effects of a new human leukocyte elastase inhibitor (recombinant guamerin) on cerulein-induced pancreatitis in rats.
Jo YJ; Choi HS; Jun DW; Lee OY; Kang JS; Park IG; Jung KH; Hahm JS
Int Immunopharmacol; 2008 Jul; 8(7):959-66. PubMed ID: 18486906
[TBL] [Abstract][Full Text] [Related]
14. Effect of urinary trypsin inhibitor on pancreatic cellular and lysosomal fragility in cerulein-induced acute pancreatitis in rats.
Hirano T; Manabe T; Tobe T
Dig Dis Sci; 1993 Apr; 38(4):660-4. PubMed ID: 7681748
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of saralasin and ramiprilat, the inhibitors of renin-angiotensin system, on cerulein-induced acute pancreatitis.
Tsang SW; Ip SP; Wong TP; Che CT; Leung PS
Regul Pept; 2003 Mar; 111(1-3):47-53. PubMed ID: 12609748
[TBL] [Abstract][Full Text] [Related]
16. Acute cytotoxic effect of cyclosporin A on pancreatic acinar cells in rats. Protective effect of the synthetic protease inhibitor E3123.
Hirano T; Manabe T; Ando K; Tobe T
Scand J Gastroenterol; 1992; 27(2):103-7. PubMed ID: 1373246
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cathepsin B does not affect the intracellular activation of trypsinogen by cerulein hyperstimulation in isolated rat pancreatic acinar cells.
Klonowski-Stumpe H; Lüthen R; Han B; Sata N; Häussinger D; Niederau C
Pancreas; 1998 Jan; 16(1):96-101. PubMed ID: 9436869
[TBL] [Abstract][Full Text] [Related]
18. The protective effect of the trypsin inhibitor urinastatin on cerulein-induced acute pancreatitis in rats.
Tani S; Otsuki M; Itoh H; Nakamura T; Fujii M; Okabayashi Y; Fujisawa T; Baba S
Pancreas; 1988; 3(4):471-6. PubMed ID: 2459695
[TBL] [Abstract][Full Text] [Related]
19. The effect of chronic alcohol administration on cerulein-induced pancreatitis.
Korsten MA; Haber PS; Wilson JS; Lieber CS
Int J Pancreatol; 1995 Aug; 18(1):25-31. PubMed ID: 7594767
[TBL] [Abstract][Full Text] [Related]
20. A new synthetic protease inhibitor, E-3123, prevents lysosomal and mitochondrial fragility in rat caerulein-induced pancreatitis.
Hirano T; Manabe T
J Int Med Res; 1992 Jun; 20(3):211-7. PubMed ID: 1383065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
